-The Hindu In the case of technologies with benefits and risks, it is important to have regulatory mechanisms which can help analyse them in an impartial manner It is 61 years since the beginning of new genetics based on the discovery of the double helix structure of the DNA molecule. It is also 31 years since the production of transgenic plants. The first patent for a living organism went to Dr. Anand...

-The Times of India NEW DELHI: The Supreme Court on Monday agreed to examine a PIL alleging a sharp increase in infant deaths after administration of pentavalent vaccine, which replaced the tried and tested vaccines to fight five deadly diseases under the universal immunization programme (UIP). PIL petitioner Yogesh Jain, a former pediatrician in AIIMS and now a public health physician at Jan Swasthya Sahyog in Bilaspur district, alleged a conspiracy in...

-The Business Standard Demand for products from the 'poor man's cow' is rising exponentially and should be encouraged. A goat is generally potrayed as a "poor man's cow". But that seems to be an understatement. Compared to cows, goats are more hardy, multi-utility, easy-to-maintain and prolific animals that can efficiently convert low-value vegetation, tree leaves and crop residues into high value meat, milk, hide, manure and fibre, including the much sought-after Pashmina...

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...

-The Guardian GDP may be an inaccurate indicator in sub-Saharan Africa, which is a concern for those who want to use statistics to help the world's poorest people Even in good financial times, development aid budgets are hardly overflowing. Government leaders and donors must make hard decisions about where to focus their limited resources. How do you decide which countries should get low-cost loans or cheaper vaccines, and which can afford to...